Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The EMBO Journal|May 3, 2003
Importin alpha-regulated nucleation of microtubules by TPX2Christoph A Schatz, Rachel Santarella, Andreas Hoenger, et al.
Oncotarget|October 23, 2018
Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer modelsMaria Quanz, Urs B Hagemann, Sabine Zitzmann-Kolbe, et al.
Frontiers in Medicine|February 2, 2023
Targeted thorium-227 conjugates as treatment options in oncologyJenny Karlsson, Christoph A Schatz, Antje M Wengner, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 31, 2017
In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patientsYasutoshi Kuboki, Christoph A Schatz, Karl Koechert, et al.
International Journal of Molecular Sciences|January 8, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer ModelsUrs B Hagemann, Christoph A Schatz, Mari I Suominen, et al.
International Journal of Molecular Sciences|February 11, 2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer ModelMari I Suominen, Matias Knuuttila, Christoph A Schatz, et al.
Molecular Cancer Therapeutics|December 8, 2011
Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9Heike M Petrul, Christoph A Schatz, Charlotte C Kopitz, et al.
Cancers|July 14, 2023
Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis ModelJenny Karlsson, Urs B Hagemann, Véronique Cruciani, et al.
Molecular Cancer Therapeutics|October 31, 2013
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft modelsNingshu Liu, Bruce R Rowley, Cathy O Bull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer ModelsStefanie Hammer, Andreas Schlicker, Sabine Zitzmann-Kolbe, et al.
Pageof 2